Patents by Inventor Mark V. Larson

Mark V. Larson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemoprevention of metachronous adenomatous colorectal polyps
    Patent number: 5945411
    Abstract: A method for protecting a colorectum against a recurrence of adenomas is provided, wherein ursodeoxycholic acid or an amide-conjugate thereof, or ursodeoxycholic acid or an amide-conjugate thereof in combination with sulindac or a phenolic NSAID is administered to a patient afflicted with colorectal adenomas in an amount effective to prevent the recurrence of colorectal adenomas following the removal thereof.
    Type: Grant
    Filed: September 23, 1998
    Date of Patent: August 31, 1999
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Mark V. Larson, David A. Ahlquist, Randall K. Pearson
  • Chemoprevention of metachronous adenomatous colorectal polyps
    Patent number: 5843929
    Abstract: A method for protecting a colorectum against a recurrence of adenomomas is provided, wherein ursodeoxycholic acid, or ursodeoxycholic acid in combination with sulindac, is administered to a patient afflicted with colorectal adenomas in an amount effective to prevent the recurrence of colorectal adenomas following the removal thereof.
    Type: Grant
    Filed: March 22, 1996
    Date of Patent: December 1, 1998
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Mark V. Larson, David A. Ahlquist, Randall K. Pearson
  • Chemoprevention of metachronous adenomatous colorectal polyps
    Patent number: 5814625
    Abstract: A method for protecting a colorectum against a recurrence of adenomas is provided, wherein ursodeoxycholic acid or an amide-conjugate thereof, or ursodeoxycholic acid or an amide-conjugate thereof in combination with sulindac or a phenolic NSAID is administered to a patient afflicted with colorectal adenomas in an amount effective to prevent the recurrence of colorectal adenomas following the removal thereof.
    Type: Grant
    Filed: September 23, 1996
    Date of Patent: September 29, 1998
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Mark V. Larson, David A. Ahlquist, Randall K. Pearson